A career in Oncology
GSK oncology is committed to the discovery and development of new oncology compounds that leverage patient-driven science to deliver improved outcomes for more patients. We have prioritized our research efforts into four key areas that we believe offer the greatest potential for transformational medicines that can help patients diagnosed with cancer.
We are constantly seeking answers to some of the most challenging questions in cancer research areas:
Join us in Oncology to help improve the lives of patients around the world. We offer global career opportunities across all areas of drug development and commercialization. Search our global career finder to see all vacancies in this area.
If you are an expert in one of the fields below, we have a role for you. Our vacancies regularly include opportunities for:
|Commercial Leadership||Scientific Leadership|
|Sales & Marketing||Medical Affairs|
|Insights & Analytics||Physicians|
|Health Economics & Outcomes Research||Clinical Development|
|Supply Chain||Regulatory Affairs|
At GSK, we have already delivered unprecedented change over the past four years, improving R&D, becoming a leader in Consumer Healthcare, strengthening our leadership, and transforming our commercial execution. Now, we’re making the most significant changes we’ve made to our business in over 20 years. We’re on track to separate and create two new companies in 2022: New GSK with a leading portfolio of vaccines and specialty medicines as well as R&D based on immune system and genetics science; and a new world-leading consumer healthcare company of loved and trusted brands.
With new ambition comes new purpose. For New GSK, this is to unite science, talent, and technology to get ahead of disease together – all with the clear ambition of delivering human health impact; stronger and more sustainable shareholder returns; and as a new GSK where outstanding people thrive.
Getting ahead means preventing disease as well as treating it. How we do all this is through our people and our culture. A culture that is ambitious for patients – so we deliver what matters better and faster; accountable for impact – with clear ownership of goals and support to succeed; and where we do the right thing. So, if you’re ready to improve the lives of billions, join us at this exciting moment in our journey. Join our challenge to get Ahead Together.
Can CRISPR help us do better detective work in the fight on cancer?
Our scientists use the power of gene editing and other functional genomics tools – plus the predictive power of AI -- to identify the clues to make better medicines. Tech helps us pinpoint cancer’s genetic signature, find new treatment combinations and even match the patient to the medicine.
No two Cancers are the same
Because no two cancers are the same and no two people are the same, our Oncology scientists are working on medicines that harness a patient’s own immune system to destroy tumors.
See what we’re doing in Oncology
GSK with iTeos Therapeutics
In June, GSK announced a strategic collaboration with iTeos Therapeutics as part of our efforts to create a leading portfolio of #oncology assets that could pave the way for the next generation of immuno-oncology therapies
We’re thrilled to be working with The Nobel Prize winning scientist Jennifer Doudna using CRISPR and creating a joint lab in San Francisco to advance our understanding of the relationship between genes and disease to help find better medicines faster.
IDEAYA and GSK announce a strategic partnership in Synthetic Lethality.
IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology
Moving Mountains for Multiple Myeloma
Addressing an unmet need for mutliple myeloma patients: recently, Shannon Altimari and Scott Miller, members of our oncology team, trekked across Iceland with Moving Mountains for Multiple Myeloma to raise awareness and funds for myeloma research. See more of their inspiring journey.
GSK completes acquisition of TESARO
We’re very excited to announce that we have successfully completed the acquisition of TESARO Inc, an oncology-focused company. We look forward to accelerating the delivery of transformational medicines to patients with cancer, together.
GSK and Lyell Immunopharma join forces to develop the next generation of cancer cell therapies
Collaboration will combine Lyell’s technologies with GSK’s pipeline of cell therapies and manufacturing capability.
Science Magazine video
We are very proud to join Science Magazine Top 20 Employers. This is a testament to our great science, new tech, and outstanding people coming together to deliver innovative medicines and vaccines.
Go behind the scenes in Oncology
See what it means to our scientists to be at the forefront of the drug development process.
Thivyan, Oncology, UK
Thivyan works in Oncology cell therapy as an External Innovation Manager. Read how he works to turn innovative research into reality.
Sumita, Oncology, US
Senior Medical Director Sumita is passionate about how transformational medicine can cure disease.
Ioanna, Oncology, UK
Read what Ioanna has to say about her experience as Head of Translational Medicine in Oncology cell therapy.
Discover other opportunities
Digital, data and analytics professionals
We’re looking for ambitious professionals in the field of digital, data and data analytics to join GSK.
Veterans at GSK
We value what you bring and believe you can successfully transfer it to a career with GSK. It’s not without challenges. But you are up for it. You have proven that. You are a member of the US military.